Stocks and Investing Stocks and Investing
Fri, February 19, 2021
Thu, February 18, 2021

Peter Lawson Maintained (BPMC) at Hold with Increased Target to $95 on, Feb 18th, 2021


Published on 2024-10-27 15:40:58 - WOPRAI, Peter Lawson
  Print publication without navigation


Peter Lawson of Barclays, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Increased Target from $90 to $95 on, Feb 18th, 2021.

Peter has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 2 agree with Peter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Konstantinos Aprilakis of "Stifel" Initiated at Hold and Held Target at $110 on, Thursday, December 3rd, 2020
  • Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Held Target at $96 on, Monday, November 2nd, 2020


These are the ratings of the 2 analyists that currently disagree with Peter


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $127 on, Tuesday, January 12th, 2021
  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $120 on, Thursday, October 29th, 2020
Contributing Sources